Vaginal Mycoplasmataceae colonization and association with immune mediators in pregnancy.


Journal

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
ISSN: 1476-4954
Titre abrégé: J Matern Fetal Neonatal Med
Pays: England
ID NLM: 101136916

Informations de publication

Date de publication:
Jul 2021
Historique:
pubmed: 14 9 2019
medline: 22 6 2021
entrez: 14 9 2019
Statut: ppublish

Résumé

To determine the prevalence of Mycoplasmataceae species in pregnant women and evaluate their association with immune system mediators. Women were prospectively enrolled between 16-22 weeks' gestation. Vaginal swabs were self-collected and analyzed with PCR for One-hundred-twenty women were enrolled and had complete lab data available. Colonization was 20.8, 2.5, 10.0, and 48.3% for MH, MG, UU, and UP, respectively. Women with any Mycoplasmataceae were more likely to be younger, of the Black race, and have public insurance. There were no significant differences in immune mediators between women with vaginal Mycoplasmataceae versus those without. After controlling for confounders, women with MH and/or MG had significantly elevated levels of IL-1β compared to women without MH or MG (estimate =  1.12; 95% CI =  0.33, 1.93). There were no other significant differences in immune mediators in women with MH and/or MG compared to those without. Colonization rates were highest for UP and lowest for MG. Higher IL-1β levels were seen in the presence of MH and/or MG, indicating that these less frequently encountered organisms may incite a stronger host response. There were no other significant differences in immune mediator levels.

Identifiants

pubmed: 31514559
doi: 10.1080/14767058.2019.1663820
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2295-2302

Auteurs

Amber M Wood (AM)

Division of Maternal-Fetal Medicine, Obstetrix Medical Group of Washington, Seattle, WA, USA.

Michelle Tang (M)

Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Diego, San Diego, CA, USA.

Tracy Truong (T)

Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, USA.

Chelsea Feldman (C)

Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Diego, San Diego, CA, USA.

Carl Pieper (C)

Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA.

Amy P Murtha (AP)

Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Maternal-Fetal Medicine, University of California, San Francisco, San Francisco, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH